Jens Ulrik Stæhr Jensen

Medicine & Life Sciences

1. Critical Illness 100%
2. Acute Kidney Injury 98%
3. Procalcitonin 76%
4. Eosinophils 66%
5. Critical Care 65%
6. Intensive Care Units 64%
7. Chronic Obstructive Pulmonary Disease 61%
8. Tazobactam Drug Combination Piperacillin 60%
9. Cefuroxime 55%
10. Adrenal Cortex Hormones 55%
11. Ciprofloxacin 52%
12. Meropenem 47%
13. Randomized Controlled Trials 46%
14. Water-Electrolyte Balance 46%
15. Equivalence Trials 46%
16. Pulmonary Surfactant-Associated Protein D 44%
17. Biomarkers 42%
18. Anti-Bacterial Agents 37%
19. Mechanical Ventilators 36%
20. Candida 35%
21. Disease Progression 34%
22. Thrombocytopenia 32%
23. Respiratory Insufficiency 32%
24. Respiratory Tract Infections 32%
25. Lung Diseases 30%
26. Kidney 28%
27. Patient Care 26%
28. Therapeutics 25%
29. Steroids 25%
30. Prednisolone 20%
31. Thrombomodulin 19%
32. Platelet Count 18%
33. Lung 18%
34. Antimicrobial Stewardship 18%
35. Ideal Body Weight 17%
36. Survival 17%
37. Infections 16%
38. Pharmaceutical Preparations 15%